BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Schumacher-schuh A, Bieger A, Borelli WV, Portley MK, Awad PS, Bandres-ciga S. Advances in Proteomic and Metabolomic Profiling of Neurodegenerative Diseases. Front Neurol 2022;12:792227. [DOI: 10.3389/fneur.2021.792227] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
Number Citing Articles
1 Rani S, Dhar SB, Khajuria A, Gupta D, Jaiswal PK, Singla N, Kaur M, Singh G, Barnwal RP. Advanced Overview of Biomarkers and Techniques for Early Diagnosis of Alzheimer's Disease. Cell Mol Neurobiol 2023. [PMID: 36847930 DOI: 10.1007/s10571-023-01330-y] [Reference Citation Analysis]
2 Fasano M, Alberio T. Neurodegenerative disorders: From clinicopathology convergence to systems biology divergence. Handb Clin Neurol 2023;192:73-86. [PMID: 36796949 DOI: 10.1016/B978-0-323-85538-9.00007-9] [Reference Citation Analysis]
3 Boonyarattanasoonthorn T, Kongratanapasert T, Maiuthed A, Hamlin R, Kijtawornrat A, Khemawoot P. Bioenhancing effects of piperine and curcumin on triterpenoid pharmacokinetics and neurodegenerative metabolomes from Centella asiatica extract in beagle dogs. Sci Rep 2022;12:20789. [PMID: 36456663 DOI: 10.1038/s41598-022-24935-7] [Reference Citation Analysis]
4 Mumtaz I, Ayaz MO, Khan MS, Manzoor U, Ganayee MA, Bhat AQ, Dar GH, Alghamdi BS, Hashem AM, Dar MJ, Ashraf GM, Maqbool T. Clinical relevance of biomarkers, new therapeutic approaches, and role of post-translational modifications in the pathogenesis of Alzheimer’s disease. Front Aging Neurosci 2022;14:977411. [DOI: 10.3389/fnagi.2022.977411] [Reference Citation Analysis]
5 Tikhonova MA, Zhanaeva SY, Shvaikovskaya AA, Olkov NM, Aftanas LI, Danilenko KV. Neurospecific Molecules Measured in Periphery in Humans: How Do They Correlate with the Brain Levels? A Systematic Review. IJMS 2022;23:9193. [DOI: 10.3390/ijms23169193] [Reference Citation Analysis]